Live Price

Crypto Coin Announcement Live Price

Breaking News

CannaCor Aims to Transform the Entire Cannabis Cultivation Process Transparent and Secure

Cannacor’s objective is to develop its own aquaponics cultivation and production facility for medical cannabis on the company’s premises in Lesotho. This will enable the company to meet growing demand in a global market of scarce production capacity and become a recognized supplier to the global markets that have no or limited production capacity.

The Medicines Agency places great emphasis on compliance with quality standards and regulative requirements on the cultivation of cannabis plants without the use of pesticides. Therefore, CannaCor has carefully evaluated various cultivation possibilities. The intention is to establish a facility where standardized, uniform and consistent products can be cultivated, without the use of pesticides, so that the content of the active ingredients is the same for each harvesting and processing stage. The development of the cultivation premises into a complete facility for the cultivation and production of medical cannabis is expected to commence in the fourth quarter of 2019. 

CannaCor Aims to Transform the Entire Cannabis Cultivation Process Transparent and Secure

Medical Cannabis is the medical use of the Cannabis sativa, Cannabis indica and various other strains to relieve symptoms of diseases and treat their conditions. The cannabis plant was used for medicinal purposes for centuries throughout the world until the early 1900s. It contains more than 100 different chemicals called cannabinoids. Each one has a different effect on the body. Delta-9- tetrahydrocannabinol (THC) and cannabidiol (CBD) are the main chemicals used in medicine.

CannaCor will take all the steps required to build the cannabis production plant according to Good Manufacturing Practices (GMP). Quality, safety, and efficacy requirements will be taken into consideration in the cultivation, harvesting and primary processing of cannabis plants intended for medicinal use or in the preparation of non-sterile medicinal cannabis products. Medicinal cannabis includes Cannabis, Cannabis materials, Cannabis preparations, Finished cannabis products.

The cultivation method and primary processing of the cannabis plant determine the ultimate properties of the active pharmaceutical ingredients (APIs). It is important to note that starting materials of herbal origin have a complex composition and can be characterized to only a limited extent through chemical or biological analysis. Therefore, an effective quality assurance system in the steps leading up to the production of the API is needed in order to guarantee reproducible quality.

CannaCor aims to ensure that the cannabis is produced hygienically to keep microbiological contamination to a minimum so as to mitigate the negative effects during cultivation, processing, and storage. Then also under conditions that ensure the therapeutic properties of the end-product are constant and reproducible. Also, under conditions that ensure that the therapeutic properties of the end-product are constant and reproducible.

Professional Team Behind this Project

As CEO, Hugo van den Dool is a dual South African and British citizen. He is a qualified construction and facility manager with more than 30 years’ experience in various sectors including commercial, retail, and housing in the UK, UAE, and South Africa. He also has extensive experience in utility-scale renewable energy and has been involved in food retail. Hugo has a BSc in Construction Management and he is a member of the British Institute of Facilities Management; he is a CITB (UK) Construction Manager and an NHBC (UK) Defects Prevention Officer. Here are other men and women behind this project which you can also check the details on

The CannaCor coin is an ERC20 coin created on the Ethereum Blockchain. CannaCor decided to use Ethereum because it has already been adopted by the masses and allows the CannaCor coin to participate in mainstream activities. Ethereum is a fast, decentralized and immutable blockchain. CannaCor will strive to achieve mass adoption in the medical cannabis sector by offering solutions that address the issues pertaining to cross-border transactions. CannaCor aims to offer solutions for the lack of banking and payment services for legal cannabis businesses.

The Content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained on our Site constitutes a solicitation, recommendation, endorsement, or offer by CCA or any third party service provider to buy or sell any securities or other financial instruments in this or in any other jurisdiction in which such solicitation or offer would be unlawful under the securities laws of such jurisdiction.

No comments